Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pancreatic Neoplasms 3Neoplasms 2Disease 2Spinal Cord Neoplasms 1Rectal Neoplasms 1Pleural Effusion 1Pleural Diseases 1Pituitary Neoplasms 1Parkinson Disease 1Pancreatitis, Chronic 1Pancreatic carcinoma, familial 1Nervous System Diseases 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Mesothelioma 1Hereditary pancreatitis 1Hematologic Diseases 1Epilepsy 1Diabetes Mellitus 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiotoxicity 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Bone Marrow Diseases 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 99Fluorouracil 90Capecitabine 86Radiotherapy 81Dexamethasone 81Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Drug Therapy 65Leucovorin 64Cetuximab 60Erlotinib Hydrochloride 56atezolizumab 53Sorafenib 53Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Clinical Laboratory Techniques × Clear all
NCT07543432 2026-04-21

STATIC

Stiftelsen Stockholms Sjukhem

Phase NA Recruiting
80 enrolled
Tumor-Agnostic

Neoplasms

NCT06664528 2025-03-04

CV_CANCER

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
300 enrolled

Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡